Due to its high sensitivity, P63 is recommended as part of a multi-antibody panel (usually along with GATA3, uroplakin II, and high-molecular-weight cytokeratin) in order to establish the urothelial lineage and rule out a secondary tumor to the bladder [17]. This evidence concerns the gene GATA3 and neoplasm.